Feasibility of a randomized controlled trial to assess treatment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia: a survey of physicians

Journal article

Open access

Peer reviewed

Yaseen M. Arabi, Farhan Al-Enezi, Kajsa-Stina Longuere, Hanan H. Balkhy, Mohamed Al-Sultan, Awad Al-Omari, Fahad M. Al-Hameed, Gail Carson, Nahoko Shindo and Robert Fowler

BMC anesthesiology, Vol.16(1), pp.36-36

12/07/2016

PMCID: PMC4942900

PMID: 27405596

Abstract

Convalescent plasma

Middle East respiratory syndrome coronavirus (MERS-CoV)

Randomized controlled trial

url

https://doi.org/10.1186/s12871-016-0198-xView

Published (Version of record) Open

1 Record Views

Title: Feasibility of a randomized controlled trial to assess treatment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia: a survey of physicians
Creators - without role: Yaseen M. Arabi - King Saud bin Abdulaziz University for Health Sciences
Farhan Al-Enezi - King Saud bin Abdulaziz University for Health Sciences
Kajsa-Stina Longuere - University of Oxford
Hanan H. Balkhy - King Saud bin Abdulaziz University for Health Sciences
Mohamed Al-Sultan - King Saud bin Abdulaziz University for Health Sciences
Awad Al-Omari - Alfaisal University
Fahad M. Al-Hameed - King Saud bin Abdulaziz University for Health Sciences
Gail Carson - University of Oxford
Nahoko Shindo - World Health Organization
Robert Fowler - University of Toronto
Publication Details: BMC anesthesiology, Vol.16(1), pp.36-36
Publisher: BioMed Central
Identifiers: 9913750108331
Academic Unit: Alfaisal University; King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences
Language: English
Resource Type: Journal article